Dr. Rishi brings more than 15 years of experience in bioprocess development, microbial fermentation, technology transfer, and biotechnology operations
The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
On a full-year basis, revenue from operations for FY26 grew 18.9 percent year-on-year to Rs 827.87 crore compared to Rs 696.48 crore in FY25
The new CRS offering is delivered from WACKER’s Biotechnology Center in Munich
Biologics manufacturing veteran brings over two decades of expertise in biosimilars, GMP operations, and large-scale biopharmaceutical manufacturing
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
FY26 revenue rises to Rs. 4,359 crore as India’s leading CDMO strengthens global footprint with EU GMP certifications, UK MHRA approval and Europe supplies
Funding to support clinical development, gene therapy pipeline expansion and GMP manufacturing capabilities
Shilpa will deliver end-to-end services including CMC development, process scale-up, GMP clinical supply, and commercial manufacturing support
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
